Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leila Dorling

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Medical Genetics|June 1, 2025
Associations between <i>ATM</i> c.7271T>G and cancer risk: analysis of Breast Cancer Association Consortium and UK Biobank dataToqir K Mukhtar, Leila Dorling, Naomi Wilcox, et al.
Familial Cancer|September 15, 2016
Hereditary breast and ovarian cancer: successful systematic implementation of a group approach to genetic counsellingPatrick R Benusiglio, Marina Di Maria, Leila Dorling, et al.
Frontiers in Genetics|October 4, 2023
Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controlsMaria Zanti, Maria A Loizidou, Denise G O'Mahony, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2015
Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy ToxicityLeila Dorling, Gillian C Barnett, Kyriaki Michailidou, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2014
Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: results from the Cambridge Breast IMRT trialMukesh B Mukesh, Wendi Qian, Jennifer S Wilkinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesisMukesh B Mukesh, Gillian C Barnett, Jennifer S Wilkinson, et al.
BMC Medicine|December 31, 2015
A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicitiesJean E Abraham, Louise Hiller, Leila Dorling, et al.
Journal of Medical Genetics|September 26, 2022
Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort studyXin Yang, Mikael Eriksson, Kamila Czene, et al.
Plos One|July 9, 2016
The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control StudyLeila Dorling, Siddhartha Kar, Kyriaki Michailidou, et al.
British Journal of Cancer|January 18, 2022
A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositisLine M H Schack, Elnaz Naderi, Laura Fachal, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Medical Genetics|June 1, 2025
Associations between <i>ATM</i> c.7271T>G and cancer risk: analysis of Breast Cancer Association Consortium and UK Biobank dataToqir K Mukhtar, Leila Dorling, Naomi Wilcox, et al.
Familial Cancer|September 15, 2016
Hereditary breast and ovarian cancer: successful systematic implementation of a group approach to genetic counsellingPatrick R Benusiglio, Marina Di Maria, Leila Dorling, et al.
Frontiers in Genetics|October 4, 2023
Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controlsMaria Zanti, Maria A Loizidou, Denise G O'Mahony, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2015
Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy ToxicityLeila Dorling, Gillian C Barnett, Kyriaki Michailidou, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2014
Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: results from the Cambridge Breast IMRT trialMukesh B Mukesh, Wendi Qian, Jennifer S Wilkinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesisMukesh B Mukesh, Gillian C Barnett, Jennifer S Wilkinson, et al.
BMC Medicine|December 31, 2015
A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicitiesJean E Abraham, Louise Hiller, Leila Dorling, et al.
Journal of Medical Genetics|September 26, 2022
Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort studyXin Yang, Mikael Eriksson, Kamila Czene, et al.
Plos One|July 9, 2016
The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control StudyLeila Dorling, Siddhartha Kar, Kyriaki Michailidou, et al.
British Journal of Cancer|January 18, 2022
A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositisLine M H Schack, Elnaz Naderi, Laura Fachal, et al.
Pageof 4